• 1
    Ahn C & Chung S. Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain Dev 1994;16: 38285.
  • 2
    Baer MT, Kozlowski BW, Blyler EM, et al. Vitamin D, calcium, and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status. Am J Clin Nutr 1997;65: 104251.
  • 3
    Weinstein RS, Bryce GF, Sappington LJ, et al. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J Clin Endocrinol Metab 1984;65: 10039.
  • 4
    Morijiri Y & Sato T. Factors causing rickets in institutionalized handicapped children on anticonvulsant therapy. Arch Dis Child 1981;56: 4469.
  • 5
    Marcus JC & Pettifor JM. Mineral metabolism in poorly nourished epileptic children. Arch Neurol 1980;37: 7724.
  • 6
    Hahn TJ, Shires R, Halstead LR. Serum dihydroxyvitamin D metabolite concentrations in patients on chronic anticonvulsant drug therapy: response to pharmacological doses of vitamin D2. Metab Bone Dis Rel Res 1983;5: 16.
  • 7
    Takeshita N, Seino Y, Ishida H, et al. Increased circulating levels of γ-carboxyglutamic acid-containing protein and decreased bone mass in children on anticonvulsant therapy. Calcif Tissue Int 1989;44: 805.
  • 8
    Livingston S, Berman W, Pauli LL. Anticonvulsant drugs and vitamin D metabolism. JAMA 1973;224: 16345.
  • 9
    Hahn TJ, Hendin BA, Scharp CR, et al. Serum 25-hydroxy calciferol levels and bone mass in children on chronic anti-epileptic therapy. N Engl J Med. 1975;292: 5504.
  • 10
    Christiansen C, Rodbro P, Tjellesen L. Pathophysiology behind anticonvulsant osteomalacia. Acta Neurol Scand 1983;94(suppl):218.
  • 11
    Dent CE, Richens A, Rowe DJF, et al. Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J 1970;4: 69.
  • 12
    Bouillon R, Reynaert J, Claes JH, et al. The effect of anticonvulsant therapy on serum levels of 25-hydroxyvitamin D, calcium and parathyroid hormone. J Clin Endocrinol Metab 1975;41: 11302.
  • 13
    Stamp TCB, Round JM, Rowe DJF, et al. Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs. Br Med J, 1972;4: 9.
  • 14
    Valimaki MJ, Tikhonen M, Laitinen K, et al. Bone mineral density measured by dual-energy absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Min Res 1994;9: 6317.
  • 15
    Sheth RD, Wesolowski CA, Jacob JC, et al. Effect of carbamazepine and valproate on bone mineral density. J Pediatr 1995;127: 25662.
  • 16
    Gillis P, Alliet P, Bruneel E, et al. Effect of valproate on bone mineral density (letter). J Pediatr 1996;128: 441.
  • 17
    Kafali G, Erselcan T, Tanzer F. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr 1999;38: 938.
  • 18
    Akin R, Okutan V, Sarici U, et al.. Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol 1998;19: 12931.
  • 19
    Lancman ACM, Mogul H, Marks S, et al. Strategies to protect bone mass in the older patients with epilepsy. Geriatrics, 1997;52: 70,7581.
  • 20
    Bikle DD. Drug-induce osteomalacia. In: FavusMJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. Philadelphia: Lippincott-Raven, 1999: 3436.
  • 21
    Rattya J, Vainionpaa L, Knip M, et al. The effects of valproate, Carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy. Pediatrics, 1999;103: 58893.
  • 22
    Duke PM, Litt IF, Gross RT. Adolescents self-assessment of sexual maturation. Pediatrics 1980;66: 91820.
  • 23
    Sorenson AW, Calkins BM, Connolly MA, et al. Comparison of nutrient intake determined by four dietary intake instruments. J Nutr Educ 1985;17: 929.
  • 24
    Hay JA. Development and testing of the Habitual Activity Estimation Scale. In: WelsmanJ, KirbyB, eds. Children and exercise XIX. Exeter: Washington Singer Press, 1995: 2:1259.
  • 25
    Faulkner RA, Baily DA, Drinkwater DT, et al. Bone densitometry in Canadian children 8-17 years old. Calcif Tissue Int 1996;59: 34451.
  • 26
    Taylor A, Konrad PT, Norman ME, et al. Total body bone mineral density in young children: influence of head bone mineral density. J Bone Min Res 1997;12: 6525.
  • 27
    Hamill PV, Drizd TA, Johnson CL, et al. Physical growth: National Center for Health Statistic percentile. Am J Clin Nutr 1979;32: 607.
  • 28
    Cioffi M, Molimari AM, Gazzero P, et al. Serum osteocalcin in 1634 healthy children. Clin Chem 1997;43: 5435.
  • 29
    Tommasi M, Bacciottini L, Benucci A, et al. Serum biochemical markers of bone turnover in healthy infants and children. Int J Biol Marker 1996;11: 15964.
  • 30
    Parviainen MT, Savolainen KE, Korhonen PH, et al. An improved method for routine determination of vitamin D and its hydroxylated metabolites in serum from children and adults. Clinica Chimica Acta 1981;114: 23347.
  • 31
    Food and Nutrition Board Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, D.C: National Academy Press,.1997: 71145.
  • 32
    Bradney M, Pearce G, Haughton G, et al. Moderate exercise during growth in prepubertal boys: changes in bone mass, size, volumetric density, and bone strength: a controlled prospective study. J Bone Min Res, 1998;13: 181421.
  • 33
    Nordstrom P & Lorentzon R. Influence of heredity and environment on bone density in adolescent boys: a parent-offspring study. Osteoporosis Int 1999;10: 2717.
  • 34
    Tsai KS, Lin JC, Chen CK, et al. Effect of exercise and exogenous glucocorticoid on serum level of intact parathyroid hormone. Int J Sports Med 1997;18: 5837.
  • 35
    Bloomfield SA, Mysiw WJ, Jackson RD. Bone mass and endocrine adaptations to training in spinal cord injured individuals. Bone 1996;19: 618.
  • 36
    Nguyen TV, Genter JR, Eisman JA. Osteoporosis in elderly men and women: effects of dietary calcium, physical activity, and body mass index. J Bone Min Res 1999;15: 32231.
  • 37
    Nishiyama S, Kuwahara T, Matsuda I. Decreased bone density in severely handicapped children and adults, with reference to the influence of limited mobility and anticonvulsont medication. Eur J Pediatr 1986;144: 45763.
  • 38
    Onoe S, Mimaki T, Seino Y, et al. Delayed bone development in epileptic children assessed by microdensitometer. Dev Pharmacol Ther 1988;11: 2431.